Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
The 1st full moon of 2026 rises tonight! Here's what to expect from January's supermoon Wolf Moon- RFK Jr. wants to scrutinize the vaccine schedule – but its safety record is already decades long
- Surprise! Saturn's huge moon Titan may not have a buried ocean after all
- Danish warship sunk by famed British admiral discovered after 225 years
- Two more UN peacekeepers killed in southern Lebanon: UNIFIL
- It's your last chance to subscribe to Paramount+ before they raise their prices: Here's how to lock in current pricing
- What we know about the 'Stranger Things' spinoff — plus the one cast member who guessed it correctly
- The most effective method to Really Adjust Hypothesis and Practice in Your Brain science Studies
- The Best 15 Applications for Efficiency and Association
